Back to search

Article

Integrated Immunophenotypic and ProMisE Molecular Profiling as Predictors of Immune Checkpoint Inhibitor Response in Endometrial Cancer

2026-02-03

Abstract excerpt

<title>Abstract</title> <p> Background: Immune checkpoint inhibitors (ICIs) are an important treatment option for recurrent endometrial cancer (EC); however, responses vary widely. Although the ProMisE molecular classification provides prognostic and predictive insights, it does not fully explain the heterogeneity of ICI outcomes. Further characterization of the tumor immune microenvironment (TIME) is required...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2471260d-796b-5e6a-90c1-38fbb782844c
DOI
10.21203/rs.3.rs-8733104/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Integrated Immunophenotypic and ProMisE Molecular Profiling as Predictors of Immune Checkpoint Inhibitor Response in Endometrial CancerDOI 10.21203/rs.3.rs-8733104/v1
Understanding the Impact of Spatial Immunophenotypes on the Survival of Endometrial Cancer Patients through the ProMisE ClassificationSemantic proximity
The Spatial Immune Landscape of Mismatch Repair Deficient Endometrial Cancer: Implications for Clinical OutcomesSemantic proximity
Toward Biology-Driven Surveillance After Endometrial Cancer Treatment: A Molecular–Clinical Framework Integrating Recurrence PhenotypeSemantic proximity
Tumor immune microenvironment in endometrial cancer of different molecular subtypes: evidence from a retrospective observational study.Semantic proximity
Desert Immune Phenotype in Endometrial Carcinoma: A Distinct Subgroup With Poor Prognosis and Targetable Mutations.Semantic proximity
Clinical features of ProMisE groups identify different phenotypes of patients with endometrial cancer.Semantic proximity
High-plex spatial transcriptomic profiling reveals distinct immune components and the HLA class I/DNMT3A/CD8 modulatory axis in mismatch repair-deficient endometrial cancerSemantic proximity
Exploration of a novel prognostic risk signatures and immune checkpoint molecules in endometrial carcinoma microenvironmentSemantic proximity
Prognostic Integrated Image-Based Immune and Molecular Profiling in Early-Stage Endometrial Cancer.Semantic proximity
The TCGA Molecular Classification of Endometrial Cancer and Its Possible Impact on Adjuvant Treatment DecisionsSemantic proximity
Integrated T-Cell Receptor Repertoire and Tumor Immunogenicity Profiling Reveals Distinct Immunogenomic States in Endometrial CancerSemantic proximity
Identification of an immune checkpoint gene signature that accurately predicts prognosis and immunotherapy response in endometrial carcinoma.Semantic proximity
Select a neighboring publication to make it the new centre.